EA200970422A1 - Аналоги пиразола - Google Patents
Аналоги пиразолаInfo
- Publication number
- EA200970422A1 EA200970422A1 EA200970422A EA200970422A EA200970422A1 EA 200970422 A1 EA200970422 A1 EA 200970422A1 EA 200970422 A EA200970422 A EA 200970422A EA 200970422 A EA200970422 A EA 200970422A EA 200970422 A1 EA200970422 A1 EA 200970422A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compounds
- pyrazole
- analogue
- disorders
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Настоящее изобретение относится к соединениям формулы (I) или их фармацевтически приемлемой соли и сольвату, где Rобозначает F или Н, и к способам их получения, к промежуточным соединениям, которые используются при их получении, к композициям, содержащим подобные соединения, и к использованию подобных соединений. Соединения по настоящему изобретению пригодны для использования при многочисленных заболеваниях, расстройствах и состояниях, в частности аллергических и респираторных заболеваниях, расстройствах и состояниях.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86733706P | 2006-11-27 | 2006-11-27 | |
PCT/IB2007/003518 WO2008065493A1 (en) | 2006-11-27 | 2007-11-14 | Pyrazole analogs |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200970422A1 true EA200970422A1 (ru) | 2009-12-30 |
EA016588B1 EA016588B1 (ru) | 2012-06-29 |
Family
ID=39226772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200970422A EA016588B1 (ru) | 2006-11-27 | 2007-11-14 | Аналоги пиразола |
Country Status (32)
Country | Link |
---|---|
US (1) | US7772269B2 (ru) |
EP (1) | EP2097407A1 (ru) |
JP (1) | JP4469924B2 (ru) |
KR (1) | KR20090074264A (ru) |
CN (1) | CN101541790A (ru) |
AP (1) | AP2009004849A0 (ru) |
AR (1) | AR063924A1 (ru) |
AU (1) | AU2007327004A1 (ru) |
BR (1) | BRPI0718672A2 (ru) |
CA (1) | CA2667566C (ru) |
CL (1) | CL2007003403A1 (ru) |
CO (1) | CO6180447A2 (ru) |
CR (1) | CR10745A (ru) |
CU (1) | CU23801B7 (ru) |
DO (1) | DOP2009000121A (ru) |
EA (1) | EA016588B1 (ru) |
EC (1) | ECSP099328A (ru) |
GE (1) | GEP20125386B (ru) |
GT (1) | GT200700104A (ru) |
HN (1) | HN2007000505A (ru) |
IL (1) | IL198412A0 (ru) |
MA (1) | MA30924B1 (ru) |
MX (1) | MX2009005526A (ru) |
NO (1) | NO20092413L (ru) |
NZ (1) | NZ576376A (ru) |
PE (1) | PE20081299A1 (ru) |
RS (1) | RS20090211A (ru) |
TN (1) | TN2009000205A1 (ru) |
TW (1) | TW200831495A (ru) |
UA (1) | UA92833C2 (ru) |
UY (1) | UY30743A1 (ru) |
WO (1) | WO2008065493A1 (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2705729C (en) | 2007-11-26 | 2012-09-18 | Pfizer Inc. | Pyrazole derivatives as 5-lo inhibitors |
EP2151450A1 (de) * | 2008-07-29 | 2010-02-10 | Sandoz AG | Verfahren zur Aufarbeitung von mikrobiologisch hergestellten zyklischen Oligopeptiden |
EP2563359A1 (en) * | 2010-04-30 | 2013-03-06 | Allergan, Inc. | Novel treatment for age related macular degeneration and ocular ischemic disease associated with complement activation by targeting 5-lipoxygenase |
US8759386B2 (en) * | 2011-01-24 | 2014-06-24 | Boehringer Ingelheim International Gmbh | Pyrazole compounds as CRTH2 antagonists |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE913866A1 (en) * | 1990-11-28 | 1992-06-03 | Ici Plc | Aryl derivatives |
EP0703913B1 (en) | 1993-06-14 | 1997-06-11 | Pfizer Inc. | Imidazoles as lipoxygenase inhibitors |
SK281577B6 (sk) * | 1994-10-18 | 2001-05-10 | Pfizer Inc. | Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze |
US5883106A (en) | 1994-10-18 | 1999-03-16 | Pfizer Inc. | 5-lipoxygenase inhibitors |
JP3400392B2 (ja) * | 1994-10-18 | 2003-04-28 | ファイザー製薬株式会社 | 5−リポキシゲナーゼ阻害剤及び新規医薬組成物 |
PT863905E (pt) | 1995-09-18 | 2001-03-30 | Pfizer | Novos inibidores da lipoxigenase do imidazolo |
US6194585B1 (en) * | 1998-12-22 | 2001-02-27 | Pfizer Inc. | Process for preparing 5-lipoxygenase inhibitors |
JP2001100682A (ja) * | 1999-09-28 | 2001-04-13 | Sanyo Electric Co Ltd | サインシステム |
JP2001100686A (ja) * | 1999-09-28 | 2001-04-13 | Hitachi Kokusai Electric Inc | 表示データ取込方法及び比較検査装置 |
-
2007
- 2007-11-14 AP AP2009004849A patent/AP2009004849A0/xx unknown
- 2007-11-14 MX MX2009005526A patent/MX2009005526A/es active IP Right Grant
- 2007-11-14 CN CNA2007800432018A patent/CN101541790A/zh active Pending
- 2007-11-14 GE GEAP200711271A patent/GEP20125386B/en unknown
- 2007-11-14 EA EA200970422A patent/EA016588B1/ru not_active IP Right Cessation
- 2007-11-14 JP JP2009538801A patent/JP4469924B2/ja not_active Expired - Fee Related
- 2007-11-14 KR KR1020097010726A patent/KR20090074264A/ko not_active Application Discontinuation
- 2007-11-14 NZ NZ576376A patent/NZ576376A/en not_active IP Right Cessation
- 2007-11-14 AU AU2007327004A patent/AU2007327004A1/en not_active Abandoned
- 2007-11-14 EP EP07848899A patent/EP2097407A1/en not_active Withdrawn
- 2007-11-14 BR BRPI0718672-0A patent/BRPI0718672A2/pt not_active IP Right Cessation
- 2007-11-14 CA CA2667566A patent/CA2667566C/en not_active Expired - Fee Related
- 2007-11-14 UA UAA200903927A patent/UA92833C2/ru unknown
- 2007-11-14 RS RSP-2009/0211A patent/RS20090211A/sr unknown
- 2007-11-14 WO PCT/IB2007/003518 patent/WO2008065493A1/en active Application Filing
- 2007-11-23 AR ARP070105216A patent/AR063924A1/es not_active Application Discontinuation
- 2007-11-26 PE PE2007001660A patent/PE20081299A1/es not_active Application Discontinuation
- 2007-11-26 GT GT200700104A patent/GT200700104A/es unknown
- 2007-11-26 HN HN2007000505A patent/HN2007000505A/es unknown
- 2007-11-26 US US11/944,732 patent/US7772269B2/en not_active Expired - Fee Related
- 2007-11-26 UY UY30743A patent/UY30743A1/es not_active Application Discontinuation
- 2007-11-26 TW TW096144833A patent/TW200831495A/zh unknown
- 2007-11-27 CL CL200703403A patent/CL2007003403A1/es unknown
-
2009
- 2009-04-23 CR CR10745A patent/CR10745A/es not_active Application Discontinuation
- 2009-04-27 IL IL198412A patent/IL198412A0/en unknown
- 2009-05-13 EC EC2009009328A patent/ECSP099328A/es unknown
- 2009-05-15 CU CU20090083A patent/CU23801B7/es not_active IP Right Cessation
- 2009-05-20 CO CO09051941A patent/CO6180447A2/es not_active Application Discontinuation
- 2009-05-22 TN TNP2009000205A patent/TN2009000205A1/fr unknown
- 2009-05-26 DO DO2009000121A patent/DOP2009000121A/es unknown
- 2009-05-27 MA MA31925A patent/MA30924B1/fr unknown
- 2009-06-24 NO NO20092413A patent/NO20092413L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201001821A1 (ru) | Производные триазола, полезные для лечения заболеваний | |
MY139690A (en) | Sulfonamide derivatives for the treatment of diseases. | |
MY143390A (en) | Sulfonamide derivatives for the treatment of diseases. | |
EA200870282A1 (ru) | Производные амина | |
WO2009066152A3 (en) | Haloallylamine inhibitors of ssao/vap-1 and uses therefor | |
UY30411A1 (es) | Derivados sustituidos del acetato de 2,3,4,-tetrahidroimidazo-[1,5-a]-pirimidin-6-amina, composiciones farmacéuticas y aplicaciones | |
EA200601462A1 (ru) | Соединения для лечения заболеваний | |
NO20084652L (no) | Deazapuriner anvendelige som inhibitorer av januskinaser | |
WO2012007877A3 (en) | N- sulfonylbenzamides as inhibitors of voltage - gated sodium channels | |
CR8649A (es) | Derivados de formamidina para el tratamiento de enfermedades | |
EA200900337A1 (ru) | Сульфонамидные производные в качестве адренергических агонистов и мускариновых антагонистов | |
PA8627001A1 (es) | Compuestos para el tratamiento de enfermedades | |
EA200870302A1 (ru) | 1,3-диоксанкарбоновые кислоты | |
EA200601510A1 (ru) | Производные фенилэтаноламина в качестве бета-2-агонистов | |
EA200870074A1 (ru) | Производные 4,5-дигидро-(1н)-пиразола в качестве модуляторов каннабиноидного рецептора св1 | |
TW200730498A (en) | Compounds | |
EA200970422A1 (ru) | Аналоги пиразола | |
MX2010008923A (es) | Compuesto (r)-n*6*-etil-6,7-dihidro-5h-indeno(5,6-d)tiazol-2,6-dia mina y su uso como antipsicotico. | |
NO20064806L (no) | Formamidderivater anvendelige som adenoceptor | |
UA86615C2 (en) | Formamide derivatives useful as adrenoceptor | |
BRPI0509137A (pt) | compostos para o tratamento de doenças | |
ECSP066700A (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
NO20064805L (no) | Sammensetninger for behandling av sykdommer | |
DOP2005000037A (es) | Compuestos utiles para el tratamiento de enfermedades | |
CR8513A (es) | Derivados de sulfonamida para el tratamiento de enfermedades |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |